OXYGEN RADICALS, NEUTROPHILS AND MYOCARDIAL INJURY
OXYGEN RADICALS, NEUTROPHILS AND MYOCARDIAL INJURY
批准号:
3365906
负责人:
Rakesh C Kukreja
金额:
$18.16万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-01-01 至 1995-12-31
关键词:
calcium transporting ATPase electron microscopy electron spin resonance spectroscopy electrophysiology free radical oxygen heart contraction high performance liquid chromatography isolation perfusion laboratory rat myocardial ischemia /hypoxia neutrophil reperfusion sarcolemma sarcoplasmic reticulum singlet oxygen
中文摘要
缺血/再灌注(I/R)损伤已被认为是重要的
病理过程;这在临床上表现为再灌注诱导
心律失常、心肌顿抑现象和
细胞坏死率。 氧衍生的自由基与
作为这种损伤的重要介质。 当前的总体目标
建议是(a)调查单线态氧是否在以下产生
I/R,(B)开发新的策略以减少这种损伤,
单线态氧清除和(c)研究潜在的生物化学,
损伤的生理和形态学机制。 因此
该项目的具体目标是检验以下假设。 的
第一种假设是单线态氧是由于I/R而产生的
离体灌流大鼠心脏。 利用电子顺磁
共振(EPR),化学发光和HPLC技术,我们将测量
单氧生成。 特定单线态氧自旋陷阱,2,2,6,6-
四甲基哌啶(TEMP)将用于EPR和HPLC测量。
单线态氧的特异性将通过清除剂如
组氨酸、色氨酸和β-胡萝卜素。 我们还将监测
收缩力,心律失常,心肌代谢,细胞膜
高渗透性肌膜和肌浆网功能,
超微结构形态学 第二个假设是单线态氧
通过聚集使肌浆网的Ca 2 +-ATP酶失活
和片段化或通过修饰氨基酸残基。 我们将
研究了暴露后Ca 2 +-ATP酶的分子结构
单线态氧 使用SDS-PAGE和HPLC技术,我们将评估
对Ca ~(2+)-ATP酶97 K道尔顿单体蛋白的损伤,
O2、H2 O2和OH自由基。 组氨酸的保护作用,
还将评价生育酚、B-胡萝卜素和抗坏血酸。 的
第三种假设是单线态氧和活化的中性粒细胞产生
严重的机械和血液动力学功能障碍,类似于I/R,
离体心脏制备。 我们将灌注辐照过的玫瑰红,
离体灌流心脏中激活的中性粒细胞和监测
等容左心室压、+和- dP/dt max、ECG和
冠状动脉血流和测量肌浆网功能,肌膜
Na+K+-ATP酶活性、巯基和脂质过氧化。 疗效
组氨酸、β-胡萝卜素、抗坏血酸、α-生育酚(对于单线态
氧),SOD,过氧化氢酶,去铁胺(O2,H2 O2,OH自由基人类
血小板(具有抗氧化活性)将在本试验中进行测试。
模型 第四个假设是单线态氧本身是直接的,
负性肌力物质,并通过以下方式发挥其负性肌力作用:
破坏心肌的兴奋-收缩耦合系统。
采用离体乳头肌等长收缩模型,
研究与单线态氧损伤相关的机械功能障碍
通过监测乳头肌收缩的变化。 的
潜在清除剂的作用(保护、改善作用和
恢复)也将进行研究。 这项工作将启动第一个
研究的目的是(1)测量单线态氧的产生,
I/R(2)证明了生理、生化和形态
自由基/中性粒细胞介导的损伤的表征。 我们
我希望我们的研究结果能帮助人们更准确地理解
单线态氧介导的生理和
生化事件
英文摘要
Ischemia/reperfusion (I/R) injury has been recognized to be an important
pathologic process; this is manifest clinically as reperfusion induced
arrhythmias, the phenomenon of myocardial stunning and an increase in the
rate of cell necrosis. Oxygen-derived free radicals have been implicated
as important mediators of this injury. The overall goals of the present
proposal are (a) to investigate if singlet oxygen is generated following
I/R, (b) to develop novel strategies to reduce this injury based on
singlet oxygen scavenging and (c) to study the underlying biochemical,
physiological and morphological mechanisms of injury. Accordingly, the
specific aims of the project are to test the following hypotheses. The
first hypothesis is that singlet oxygen is generated as a result of I/R
in the isolated perfused rat heart. Using electron paramagnetic
resonance (EPR), chemiluminescence and HPLC techniques we will measure
single oxygen generation. Specific singlet oxygen spin trap, 2,2,6,6-
tetramethylpiperidine (TEMP) will be used in EPR and HPLC measurements.
Specificity of singlet oxygen will be confirmed by scavengers such as
histidine, tryptophan and B-carotene. We will also monitor
contractility, arrhythmia, myocardial metabolism, cell membrane
hyperpermeability sarcolemmal and sarcoplasmic reticulum functions and
ultrastructural morphology. The second hypothesis is that singlet oxygen
inactivates Ca2+-ATPase enzyme of sarcoplasmic reticulum by aggregation
and fragmentation or by modification of amino acid residues. We shall
study the molecular structure of Ca2+-ATPase following exposure to
singlet oxygen. Using SDS-PAGE and HPLC techniques, we shall assess the
damage to the 97 K dalton monomer protein of Ca2+-ATPase and compare with
O2, H2O2 and OH radical. Protective effects of histidine, alpha-
tocopherol B-carotene and ascorbic acid will also be evaluated. The
third hypothesis is that singlet oxygen and activate neutrophils produce
significant mechanical and hemodynamic dysfunction, similar to I/R in the
isolated heart preparation. We will perfuse irradiated rose bengal and
activated neutrophils in the isolated perfused heart and monitor
isovolumetric left ventricular pressure, + and - dP/dt max, ECG and
coronary flow and measure sarcoplasmic reticulum function, sarcolemmal
Na+K+-ATPase activity, thiol groups and lipid peroxidation. The efficacy
of histidine beta-carotene, ascorbic acid, alpha-tocopherol (for singlet
oxygen), SOD, catalase, deferoxamine (O2, H2O2, OH radical human
platelets (which possess antioxidative activity) will be tested in this
model. the fourth hypothesis is that singlet oxygen itself is a direct,
negative inotropic species and exerts its negative inotropic action by
disrupting the excitation-contraction coupling system of cardiac muscle.
Using isolated papillary muscle isometric contraction model we shall
study the mechanical dysfunction associated with singlet oxygen injury
by monitoring alterations in contraction of the papillary muscle. The
effects of potential scavengers (protective, ameliorating effect and
recovery) will also be studied. This work will initiate one of the first
studies aimed at (1) measuring the generation of singlet oxygen following
I/R (2) demonstrating the physiological, biochemical and morphological
characterization of free radicals/neutrophils mediated injury. We
anticipate that our findings will foster a precise understanding of the
role and mechanism(s) of singlet oxygen mediated physiological and
biochemical events.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BMP-7 Modulates Inflammation induced cell death in Diabetic Cardiac and Skeletal Muscle
-
批准号:9788441
-
项目类别:
-
资助金额:$58.7万
-
财政年份:2018
-
负责人:Rakesh C Kukreja
-
依托单位:
BMP-7 Modulates Inflammation induced cell death in Diabetic Cardiac and Skeletal Muscle
-
批准号:10242150
-
项目类别:
-
资助金额:$58.7万
-
财政年份:2018
-
负责人:Rakesh C Kukreja
-
依托单位:
Amelioration of Doxorubicin Induced Muscle Dysfunction with Embryoinic stem cells-Derived Exosomes
-
批准号:10322656
-
项目类别:
-
资助金额:$49.0万
-
财政年份:2018
-
负责人:Rakesh C Kukreja
-
依托单位:
BMP-7 Modulates Inflammation induced cell death in Diabetic Cardiac and Skeletal Muscle
-
批准号:10376557
-
项目类别:
-
资助金额:$37.81万
-
财政年份:2018
-
负责人:Rakesh C Kukreja
-
依托单位:
ROS, Inflammation, and Cardioprotection in Type 2 Diabetes
-
批准号:8701394
-
项目类别:
-
资助金额:$49.36万
-
财政年份:2013
-
负责人:Rakesh C Kukreja
-
依托单位:
ROS, Inflammation, and Cardioprotection in Type 2 Diabetes
-
批准号:8522552
-
项目类别:
-
资助金额:$47.87万
-
财政年份:2013
-
负责人:Rakesh C Kukreja
-
依托单位:
Health Educational Research Opportunities (HERO)
-
批准号:7797605
-
项目类别:
-
资助金额:$9.31万
-
财政年份:2008
-
负责人:Rakesh C Kukreja
-
依托单位:
Health Educational Research Opportunities (HERO)
-
批准号:7617652
-
项目类别:
-
资助金额:$9.31万
-
财政年份:2008
-
负责人:Rakesh C Kukreja
-
依托单位:
Cardioprotective Signaling following Phosphodiesterase-5 Inhibition
-
批准号:8258744
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2008
-
负责人:Rakesh C Kukreja
-
依托单位:
Cardioprotective Signaling following Phosphodiesterase-5 Inhibition
-
批准号:7867829
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2008
-
负责人:Rakesh C Kukreja
-
依托单位:
Health Educational Research Opportunities (HERO)
-
批准号:8056464
-
项目类别:
-
资助金额:$9.31万
-
财政年份:2008
-
负责人:Rakesh C Kukreja
-
依托单位:
Health Educational Research Opportunities (HERO)
-
批准号:7475537
-
项目类别:
-
资助金额:$9.31万
-
财政年份:2008
-
负责人:Rakesh C Kukreja
-
依托单位:
Health Educational Research Opportunities (HERO)
-
批准号:8286343
-
项目类别:
-
资助金额:$9.31万
-
财政年份:2008
-
负责人:Rakesh C Kukreja
-
依托单位:
Cardioprotective Signaling following Phosphodiesterase-5 Inhibition
-
批准号:8094423
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2008
-
负责人:Rakesh C Kukreja
-
依托单位:
Cardioprotective Signaling following Phosphodiesterase-5 Inhibition
-
批准号:7655523
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2008
-
负责人:Rakesh C Kukreja
-
依托单位:
CARDIOPROTECTIVE EFFECTS OF PDE-5 INHIBITORS
-
批准号:6863287
-
项目类别:
-
资助金额:$45.47万
-
财政年份:2005
-
负责人:Rakesh C Kukreja
-
依托单位:
Cardioprotective Effects of PDE-5 Inhibitors
-
批准号:8206609
-
项目类别:
-
资助金额:$44.05万
-
财政年份:2005
-
负责人:Rakesh C Kukreja
-
依托单位:
Cardioprotective Effects of PDE-5 Inhibitors
-
批准号:7790958
-
项目类别:
-
资助金额:$44.85万
-
财政年份:2005
-
负责人:Rakesh C Kukreja
-
依托单位:
CARDIOPROTECTIVE EFFECTS OF PDE-5 INHIBITORS
-
批准号:7002638
-
项目类别:
-
资助金额:$44.07万
-
财政年份:2005
-
负责人:Rakesh C Kukreja
-
依托单位:
CARDIOPROTECTIVE EFFECTS OF PDE-5 INHIBITORS
-
批准号:7173444
-
项目类别:
-
资助金额:$45.05万
-
财政年份:2005
-
负责人:Rakesh C Kukreja
-
依托单位:
海外基金